🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10301+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10301 recruiting trials

NARecruitingNCT07275190

The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome

🏥 Fondazione IRCCS Policlinico San Matteo di Pavia📍 1 site📅 Started Jun 2025View details ↗
Phase 1, PHASE2RecruitingNCT07022964

CD5 CAR T-Cell Therapy for r/r T-cell Lymphomas

👨‍⚕️ Tengyu Wang, Ph.D, Beijing GoBroad Hospital, Beijing, Beijing 102200📍 3 sites📅 Started Jun 2025View details ↗
NARecruitingNCT07141225

Application of the "Off-Clamp And Sutureless" Technique in Robot-Assisted Partial Nephrectomy

👨‍⚕️ Pengfei Shao, Professor, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital), Nanjing, Jiangsu 210036📍 1 site📅 Started Jun 2025View details ↗
RecruitingNCT07037732

Circulating B-cell, Drug and Anti-drug Antibodies Monitoring in Patients Treated With Rituximab for Autoimmune Disorders

🏥 Centre Hospitalier Universitaire de Nice📍 1 site📅 Started Jun 2025View details ↗
Enrolling by InvitationNCT07090382

Prospective Validation of the STOPSHOCK Score - Artificial Intelligence Based Predictive Scoring System to Identify the Risk of Developing Cardiogenic Shock (CS) in Patients Suffering From Acute Coronary Syndrome (ACS)

👨‍⚕️ Allan Böhm, MD, PhD, MSc, MBA, FESC, FJCS, Premedix Academy📍 1 site📅 Started Jun 2025View details ↗
Phase 3RecruitingNCT07503730

Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid (ATRA) for Treating Acute Promyelocytic Leukemia (APL).

🏥 First Affiliated Hospital Xi'an Jiaotong University📍 1 site📅 Started Jun 2025View details ↗
Phase 1RecruitingNCT07321626

Romiplostim N01 for Platelet Recovery After Haploidentical HSCT

🏥 First Affiliated Hospital of Zhejiang University📍 1 site📅 Started Jun 2025View details ↗
NARecruitingNCT06761469

Leprosy Active Searching Trial in Brazil

👨‍⚕️ Rosa C Lucchetta, PhD, Hospital Alemão Oswaldo Cruz📍 1 site📅 Started Jun 2025View details ↗
NARecruitingNCT07008989

A VIRTUAL Three-month Intervention Study of the Effects of a Smartphone Application (HippoCamera) on Memory in Teens and Young Adults With Down Syndrome

🏥 Boston College📍 1 site📅 Started Jun 2025View details ↗
Phase 1, PHASE2RecruitingNCT07063875

Adding IL-2 to Tebentafusp to Eradicate Cancer Progression

👨‍⚕️ Anthony Joshua, FRACP, St Vincent's Hospital, Sydney📍 2 sites📅 Started Jun 2025View details ↗
EARLY_Phase 1RecruitingNCT06765733

The Study of Safety and Preliminary Efficacy of Aleeto in Patients With MultIple System Atrophy

👨‍⚕️ Yilong Wang, M.D., Beijing Tiantan Hospital, Capital Medical University, Beijing, China📍 1 site📅 Started May 2025View details ↗
Phase 1, PHASE2RecruitingNCT06922591

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

👨‍⚕️ Maxim Pimpkin, MD, PhD, Tango Therapeutics, Inc.📍 12 sites📅 Started May 2025View details ↗
NARecruitingNCT03725670

Direct Lentiviral Injection Gene Therapy for MLD

👨‍⚕️ Lung-Ji Chang, Ph.D, Shenzhen Geno-Immune Medical Institute📍 1 site📅 Started May 2025View details ↗
Phase 1, PHASE2RecruitingNCT06533579

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

👨‍⚕️ Vironexis Clinical Trials, Vironexis Biotherapeutics Inc.📍 9 sites📅 Started May 2025View details ↗
NARecruitingNCT07087873

Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases

🏥 Xuanwu Hospital, Beijing📍 1 site📅 Started May 2025View details ↗
NARecruitingNCT06983366

Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases

👨‍⚕️ Ahmad M. Shaddad, MD, Assiut University📍 1 site📅 Started May 2025View details ↗
RecruitingNCT06505603

PiMZ Longitudinal Cohort (PiMZ Logic)

👨‍⚕️ Monica Goldklang, MD, Columbia University📍 5 sites📅 Started May 2025View details ↗
Phase 2, PHASE3RecruitingNCT06947499

A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series

🏥 LG Chem📍 1 site📅 Started May 2025View details ↗
Phase 2RecruitingNCT06302569

Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma

👨‍⚕️ Giuseppe Procopio, MD, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy📍 1 site📅 Started May 2025View details ↗
Phase 1RecruitingNCT07359417

MR-Guided Radiotherapy Dose Escalation Trial for Esophageal Squamous Cell Carcinoma

🏥 UMC Utrecht📍 1 site📅 Started May 2025View details ↗
← PreviousPage 104 of 516Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →